Home › Angelman Syndrome › Illinois › Chicago
Angelman Syndrome clinical trials in Chicago, IL
3 studies for Angelman Syndrome are looking for participants at sites in and around Chicago (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
BEACON - Phase III Clinical Study of Rugonersen in Angelman Syndrome.
RecruitingPhase 3
- Rush University, Chicago
A Phase 1/2 Study of the Safety and Efficacy of MVX-220 in Angelman Syndrome
RecruitingPhase 1/2
- Rush University Medical Center, Chicago
Angelman Syndrome Natural History Study
RecruitingObservational study
- Rush University Children's Hospital, Chicago
Angelman Syndrome trials in other cities
Other studies in Chicago
- Non-Small Cell Lung Cancer61 studies
- Breast Cancer58 studies
- Cancer (all types)51 studies
- Metastatic Cancer45 studies
- Prostate Cancer45 studies
- Obesity41 studies
- Lung Cancer41 studies
- Ovarian Cancer36 studies
- Stroke34 studies
- Colorectal Cancer33 studies
- Heart Failure31 studies
- Overweight28 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.